David Norwood
Research Subjects
David Norwood has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
William Hurtle
United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland,1 Clinical Research Management, Hinckley, Ohio2
3 shared publicationsElizabeth Bode
United States Army Medical Research Institute of Infectious Diseases, Diagnostic Systems Division, 1425 Porter St., Fort Detrick, MD 21702, USA
2 shared publicationsBonnie Loveless
Clinical Research Management, North Royalton, Ohio 44133,1 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21701-5011,2 Battelle, Columbus, Ohio 43201,3 Geo-Centers, Newtown, Massachusetts 024594
1 shared publicationDavid A. Kulesh
Clinical Research Management, North Royalton, Ohio 44133,1 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21701-5011,2 Battelle, Columbus, Ohio 43201,3 Geo-Centers, Newtown, Massachusetts 024594
1 shared publicationDavid Shoemaker
Clinical Research Management, North Royalton, Ohio,1 Walter Reed Army Institute of Research, Silver Spring, Maryland,2 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland3
1 shared publicationDeanna Bridge
Clinical Research Management, North Royalton, Ohio 44133,1 U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21701-5011,2 Battelle, Columbus, Ohio 43201,3 Geo-Centers, Newtown, Massachusetts 024594
1 shared publication
Latest Publications
- 31 August 2005
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 19 (4) , 298
“Development of a novel internal positive control for TaqmanR based assays” [YMCPR 19(1):51–9]
- 31 August 2005
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 19 (4) , 298
“Development of a novel internal positive control for TaqmanR based assays” [YMCPR 19(1):51–9]
- Open Access
- 1 December 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (12) , 5825-5831
Real-Time PCR Assay for a Unique Chromosomal Sequence of Bacillus anthracis
Real-time PCR has become an important method for the rapid identification of Bacillus anthracis since the 2001 anthrax mailings. Most real-time PCR assays for B. anthracis have been developed to detect virulence genes located on the pXO1 and pXO2 plasmids. In contrast, only two published chromosomal targets exist, the rpoB gene and the gyrA gene. In the present study, subtraction-hybridization with a plasmid-cured B. anthracis tester strain and a Bacillus cereus driver was used to find a unique chromosomal sequence. By targeting this region, a real-time assay was developed with the Ruggedized Advanced Pathogen Identification Device. Further testing has revealed that the assay has 100% sensitivity and 100% specificity, with a limit of detection of 50 fg of DNA. The results of a search for sequences with homology with the BLAST program demonstrated significant alignment to the recently published B. anthracis Ames strain, while an inquiry for protein sequence similarities indicated homology with an abhydrolase from B. anthracis strain A2012. The importance of this chromosomal assay will be to verify the presence of B. anthracis independently of plasmid occurrence.
- 1 December 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (12) , 5825-5831
Open AccessReal-Time PCR Assay for a Unique Chromosomal Sequence of Bacillus anthracis
Real-time PCR has become an important method for the rapid identification of Bacillus anthracis since the 2001 anthrax mailings. Most real-time PCR assays for B. anthracis have been developed to detect virulence genes located on the pXO1 and pXO2 plasmids. In contrast, only two published chromosomal targets exist, the rpoB gene and the gyrA gene. In the present study, subtraction-hybridization with a plasmid-cured B. anthracis tester strain and a Bacillus cereus driver was used to find a unique chromosomal sequence. By targeting this region, a real-time assay was developed with the Ruggedized Advanced Pathogen Identification Device. Further testing has revealed that the assay has 100% sensitivity and 100% specificity, with a limit of detection of 50 fg of DNA. The results of a search for sequences with homology with the BLAST program demonstrated significant alignment to the recently published B. anthracis Ames strain, while an inquiry for protein sequence similarities indicated homology with an abhydrolase from B. anthracis strain A2012. The importance of this chromosomal assay will be to verify the presence of B. anthracis independently of plasmid occurrence.
- Open Access
- 1 January 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (1) , 179-185
Detection of the Bacillus anthracis gyrA Gene by Using a Minor Groove Binder Probe
Identification of chromosomal markers for rapid detection of Bacillus anthracis is difficult because significant chromosomal homology exists among B. anthracis , Bacillus cereus , and Bacillus thuringiensis . We evaluated the bacterial gyrA gene as a potential chromosomal marker for B. anthracis . A real-time PCR assay was developed for the detection of B. anthracis . After analysis of the unique nucleotide sequence of the B. anthracis gyrA gene, a fluorescent 3′ minor groove binding probe was tested with 171 organisms from 29 genera of bacteria, including 102 Bacillus strains. The assay was found to be specific for all 43 strains of B. anthracis tested. In addition, a test panel of 105 samples was analyzed to evaluate the potential diagnostic capability of the assay. The assay showed 100% specificity, demonstrating the usefulness of the gyrA gene as a specific chromosomal marker for B. anthracis .
- 1 January 2004
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (1) , 179-185
Open AccessDetection of the Bacillus anthracis gyrA Gene by Using a Minor Groove Binder Probe
Identification of chromosomal markers for rapid detection of Bacillus anthracis is difficult because significant chromosomal homology exists among B. anthracis , Bacillus cereus , and Bacillus thuringiensis . We evaluated the bacterial gyrA gene as a potential chromosomal marker for B. anthracis . A real-time PCR assay was developed for the detection of B. anthracis . After analysis of the unique nucleotide sequence of the B. anthracis gyrA gene, a fluorescent 3′ minor groove binding probe was tested with 171 organisms from 29 genera of bacteria, including 102 Bacillus strains. The assay was found to be specific for all 43 strains of B. anthracis tested. In addition, a test panel of 105 samples was analyzed to evaluate the potential diagnostic capability of the assay. The assay showed 100% specificity, demonstrating the usefulness of the gyrA gene as a specific chromosomal marker for B. anthracis .
- 1 July 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (7) , 3273-3283
Detection and Identification of Ciprofloxacin-Resistant Yersinia pestis by Denaturing High-Performance Liquid Chromatography
Denaturing high-performance liquid chromatography (DHPLC) has been used extensively to detect genetic variation. We used this method to detect and identify Yersinia pestis KIM5 ciprofloxacin-resistant isolates by analyzing the quinolone resistance-determining region (QRDR) of the gyrase A gene. Sequencing of the Y. pestis KIM5 strain gyrA QRDR from 55 ciprofloxacin-resistant isolates revealed five mutation types. We analyzed the gyrA QRDR by DHPLC to assess its ability to detect point mutations and to determine whether DHPLC peak profile analysis could be used as a molecular fingerprint. In addition to the five mutation types found in our ciprofloxacin-resistant isolates, several mutations in the QRDR were generated by site-directed mutagenesis and analyzed to further evaluate this method for the ability to detect QRDR mutations. Furthermore, a blind panel of 42 samples was analyzed by screening for two mutant types to evaluate the potential diagnostic value of this method. Our results showed that DHPLC is an efficient method for detecting mutations in genes that confer antibiotic resistance.
- 1 July 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (7) , 3273-3283
Detection and Identification of Ciprofloxacin-Resistant Yersinia pestis by Denaturing High-Performance Liquid Chromatography
Denaturing high-performance liquid chromatography (DHPLC) has been used extensively to detect genetic variation. We used this method to detect and identify Yersinia pestis KIM5 ciprofloxacin-resistant isolates by analyzing the quinolone resistance-determining region (QRDR) of the gyrase A gene. Sequencing of the Y. pestis KIM5 strain gyrA QRDR from 55 ciprofloxacin-resistant isolates revealed five mutation types. We analyzed the gyrA QRDR by DHPLC to assess its ability to detect point mutations and to determine whether DHPLC peak profile analysis could be used as a molecular fingerprint. In addition to the five mutation types found in our ciprofloxacin-resistant isolates, several mutations in the QRDR were generated by site-directed mutagenesis and analyzed to further evaluate this method for the ability to detect QRDR mutations. Furthermore, a blind panel of 42 samples was analyzed by screening for two mutant types to evaluate the potential diagnostic value of this method. Our results showed that DHPLC is an efficient method for detecting mutations in genes that confer antibiotic resistance.